Researchers have found the first direct evidence that autoimmunity plays a role in Parkinson’s disease.
Columbia scientists observed how molecules that regulate chemical signaling in the brain interact with the AMPA receptor, governing brain function.
A drug that boosts activity in the brain’s “garbage disposal” system can decrease levels of toxic proteins associated with Alzheimer’s disease and other neurodegenerative disorders and improve cognition in mice.
A new study measures the risk of developing Parkinson's for people with Gaucher disease and Gaucher carriers.
Researchers have identified two types of neurons that enable the spinal cord to control skilled forelimb movement. The findings could lead to new ways to treat movement disorders.
New findings that overturn a theory about the brain and the immune system suggest Parkinson's may be an autoimmune disease.